NYSE - Delayed Quote • USD
ResMed Inc. (RMD)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:58 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 4 | 12 | 12 |
| Avg. Estimate | 1.96 | 1.91 | 7.4 | 8.19 |
| Low Estimate | 1.86 | 1.84 | 7.24 | 7.92 |
| High Estimate | 2.09 | 2 | 7.63 | 8.85 |
| Year Ago EPS | 1.6 | 1.64 | 6.44 | 7.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 4 | 17 | 17 |
| Avg. Estimate | 1.19B | 1.17B | 4.63B | 4.95B |
| Low Estimate | 1.17B | 1.14B | 4.59B | 4.81B |
| High Estimate | 1.23B | 1.18B | 4.68B | 5.05B |
| Year Ago Sales | 1.12B | 1.1B | 4.22B | 4.63B |
| Sales Growth (year/est) | 6.40% | 6.20% | 9.70% | 6.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.69 | 1.62 | 1.8 | 1.91 |
| EPS Actual | 1.6 | 1.64 | 1.88 | 2.13 |
| Difference | -0.09 | 0.02 | 0.08 | 0.22 |
| Surprise % | -5.30% | 1.20% | 4.40% | 11.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.96 | 1.91 | 7.4 | 8.19 |
| 7 Days Ago | 1.96 | 1.91 | 7.41 | 8.2 |
| 30 Days Ago | 1.96 | 1.91 | 7.45 | 8.13 |
| 60 Days Ago | 1.96 | 1.91 | 7.45 | 8.13 |
| 90 Days Ago | 1.96 | 1.9 | 7.4 | 8.09 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | RMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 22.50% | -- | -- | 6.50% |
| Next Qtr. | 16.50% | -- | -- | 12.00% |
| Current Year | 14.90% | -- | -- | 5.30% |
| Next Year | 10.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 13.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 13.05% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 4/26/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/26/2024 |
| Maintains | Keybanc: Overweight to Overweight | 4/26/2024 |
| Maintains | Needham: Buy to Buy | 4/26/2024 |
| Maintains | Needham: Buy to Buy | 4/1/2024 |
| Maintains | Mizuho: Buy to Buy | 3/27/2024 |
Related Tickers
WST West Pharmaceutical Services, Inc.
360.43
-2.10%
BDX Becton, Dickinson and Company
231.55
+0.46%
RGEN Repligen Corporation
166.58
+0.56%
TFX Teleflex Incorporated
206.71
0.00%
COO The Cooper Companies, Inc.
88.84
-1.21%
ATR AptarGroup, Inc.
143.33
+2.25%
ISRG Intuitive Surgical, Inc.
375.33
+0.59%
XRAY DENTSPLY SIRONA Inc.
30.57
+0.72%
BAX Baxter International Inc.
40.13
-0.25%
ALC Alcon Inc.
78.77
-0.09%